(Q40024961)

16 September 2017

title

Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort (English)

1 reference

16 September 2017

1 reference

1 reference

4

Keith S Kaye

1 reference

16 September 2017

5

Michael J Rybak

1 reference

16 September 2017

1

Ravina Kullar

1 reference

16 September 2017

Susan L Davis

2

1 reference

16 September 2017

Thomas N Taylor

series ordinal

3

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 March 2012

1 reference

16 September 2017

1 reference

16 September 2017

volume

32

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

195-201

1 reference

16 September 2017

cites work

Vancomycin: a history

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Vancomycin: a 50-year reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Decreasing in vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York Hospital: quantitative testing redux

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Serum Vancomycin Concentrations: Reappraisal of Their Clinical Value

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2011.01017.X

10.1002/J.1875-9114.2011.01017.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference